See also this year's filing and all EDGAR filings for this company.
PDF Report 0001444192_2021_Acasti_Pharma_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001444192', 'EntityCommonStockSharesOutstanding': 92488385, 'Assets': 22853000, 'AssetsCurrent': 16079000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 4244000, 'Liabilities': 9859000, 'LiabilitiesAndStockholdersEquity': 22853000, 'LiabilitiesCurrent': 7395000, 'LiabilitiesNoncurrent': 71000, 'NetIncome': -25513000, 'PropertyPlantAndEquipmentNet': 1910000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 620000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 2393000, 'remainder_LiabilitiesAndStockholdersEquity': 12994000, 'remainder_NetIncome': -25513000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001444192')"} |
Edgar->Model Mapping
